RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Immune-Onc Therapeutics

Immune-Onc Therapeutics

Charting a New Course in Immunology and Oncology Drug Development.

Latest funding

$131M Series B+ ·

Led by TriWise Capital · Source: startupintros.com

Total raised: $211M across 3 sourced rounds

All 3 rounds ↓
Website: immune-onc.com.
X: @ImmuneOnc · 241 followers.
LinkedIn: linkedin.com.
Sectors: Biopharma, Biotechnology, Health Care, Medical, Oncology.
Stage: Series B+.
Based in: Palo Alto, United States.
Total raised: $211M in 3 sourced rounds.
Last round: Jan 5, 2023 · 1,411 days ago.
Headcount: 11–50 employees.
On Recent Funding since: Oct 1, 2026.

Signals

X account@ImmuneOnc · created Aug 24, 2016 (10 years old) · 241 followers
Website registeredMar 2, 2016 (10 years old)
TIMELINE · MONEY RAISED

Immune-Onc Therapeutics | 188 days from website to first raise on record

@ImmuneOnc·Raised $211M in 3 sourced rounds·2 signals before the first raise
$53M$106M$158M$211MMARAUGJAN 2019JUNNOVAPRSEPFEB$211M||WEBSITE CREATED · MAR 2, 2016||X ACCOUNT CREATED @IMMUNEONC · AUG 24, 2016$7M Series A · Sep 6, 2016$7M A · SEP '16$73M Series B+ · Mar 30, 2021$73M B+ · MAR '21$131M Series B+ · Jan 5, 2023$131M B+ · JAN '23

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

DateRoundAmountLeadSource
Series B+$131MTTriWise Capitalstartupintros.com
Series B+$73MOOceanpine Capitalstartupintros.com
Series A$7M—startupintros.com

Timeline

  1. X account created
  2. Website created

Founders and team

Investors

Companies like Immune-Onc Therapeutics

Other companies backed by TriWise Capital

TriWise Capital portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/immune-onc-therapeutics (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy